A combination of the preoperative neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios as a useful predictor of survival outcomes following the transarterial chemoembolization of huge hepatocellular carcinoma
Open Access
- 1 April 2020
- journal article
- research article
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 41 (4) , 376-382
Abstract
To investigate the prognostic value of neutrophil-to-lymphocyte ratio (NLR) plus the lymphocyte-to-monocyte ratio (LMR) to predict survival outcomes in huge hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE). There were 180 huge HCC patients undergoing TACE between 2011 and 2017 were retrospectively analyzed. Patients who has an increased NLR (greater than 3.94) and a decreased LMR (≤2.20) were assessed score 2 according to receiver operating characteristic (ROC) curve, and patients who were assigned with 1, with one of these characteristic or 0 with neither of these characteristics. We used univariate and multivariate analyses for evaluations of the predicative NLR, LMR and other values about overall survival (OS) using multivariate Cox's regression. The liver function index such as aspartate transaminase, alanine transaminase, and total bilirubin, as well as in ammatory biomarkers like absolute neutrophil count, monocyte count, lymphocyte count, seemed much larger than the groups with an NLR-LMR score of 2 than in the other 2 groups (p less than 0.05 for all), including BCLC stage. Higher NLR plus a low level of LMR predicted a short median OS. Multivariate Cox's regression revealed that an NLR-LMR score of 2 was a useful predictor of OS in huge HCC patients after TACE. The pretreatment NLR plus LMR are effective for predicting survival outcomes in huge HCC patients after TACE.Keywords
This publication has 20 references indexed in Scilit:
- Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resectionJournal of Surgical Oncology, 2017
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology, 2017
- Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysisSurgery Today, 2016
- Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus‐associated hepatocellular carcinoma patients after curative hepatectomyJournal of Surgical Oncology, 2016
- Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolizationOncology Letters, 2016
- Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinomaHepatology, 2015
- Recurrent hepatocellular carcinoma: A Western strategy that emphasizes the impact of pathologic profile of the first resectionSurgery, 2015
- Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resectionWorld Journal of Gastroenterology, 2015
- Tumor-Associated Macrophage Promotes Tumor Progression via STAT3 Signaling in Hepatocellular CarcinomaPathobiology, 2013
- Novel advancements in the management of hepatocellular carcinoma in 2008Journal of Hepatology, 2008